Gill Capital Partners’s Teladoc Health TDOC Stock Holding History

Gill Capital Partners’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$475	Hold	56	–	–	﹤0.01%	645
2026 Q1	$305	Buy	+56	New	+$314	﹤0.01%	653

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Gill Capital Partners's TDOC Position: Q2 2026 in Review

Gill Capital Partners held its Teladoc Health (TDOC) position steady in Q2 2026 at 56 shares worth $475. The position accounts for ﹤0.01% of the portfolio, ranked #645.

Gill Capital Partners first reported a position in TDOC in Q1 2026 and has held it in 2 quarters since. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

Gill Capital Partners held 56 shares of Teladoc Health worth $475 as of Q2 2026.
Gill Capital Partners left its Teladoc Health share count unchanged in Q2 2026.
Teladoc Health made up ﹤0.01% of Gill Capital Partners's portfolio in Q2 2026, its #645 holding.
Gill Capital Partners first reported a position in Teladoc Health in Q1 2026 and has held it in 2 quarters since.
348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Gill Capital Partners's 13F filing for Q2 2026, filed 20 Aug 2026.